| Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
 | HR (95% CI) | p | HR (95% CI) | p |
Gender | ||||
 Female | 1 |  |  |  |
 Male | 1.23 (0.98–1.50) | 0.076 |  |  |
Stage | ||||
 I | 1 |  | 1 |  |
 II | 1.70 (0.94–3.10) | 0.082 | 1.45 (0.79–2.66) | 0.225 |
 III | 2.34 (1.28–4.25) | 0.006 | 1.74 (0.95–3.21) | 0.074 |
 IV | 8.26 (4.50–15.18) | < 0.001 | 6.07 (3.25–11.35) | < 0.001 |
Location | ||||
 Left colon, rectum | 1 |  |  |  |
 Right colon | 1.13 (0.90–1.42) | 0.304 |  |  |
Microsatellite | ||||
 MSI | 1 |  |  |  |
 MSS | 1.11 (0.78–1.58) | 0.566 |  |  |
CMS | ||||
 CMS1 | 1 |  | 1 |  |
 CMS2 | 0.97 (0.67–1.38) | 0.848 | 0.94 (0.63–1.39) | 0.743 |
 CMS3 | 0.70 (0.42–1.16) | 0.171 | 0.67 (0.37–1.17) | 0.160 |
 CMS4 | 1.45 (1.00–2.11) | 0.049 | 1.10 (0.74–1.64) | 0.625 |
 Indeterminate | 1.55 (0.98–2.46) | 0.064 | 1.41 (0.87–2.29) | 0.159 |
KRAS status | ||||
 Wild-type | 1 |  | 1 |  |
 Mutated | 1.27 (1.01–1.61) | 0.043 | 1.29 (1.00–1.66) | 0.048 |
BRAF status | ||||
 Wild-type | 1 |  |  |  |
 Mutated | 1.23 (0.85–1.79) | 0.28 |  |  |
TP53 status | ||||
Wild-type | 1 | Â | Â | Â |
Mutated | 1.20 (0.92–1.57) |  |  |  |
CIMP | ||||
 Low | 1 |  |  |  |
 High | 1.14 (0.83–1.57) |  |  |  |
Group | ||||
 Group I + II | 1 |  | 1 |  |
 Group III | 1.68 (1.30–2.17) | < 0.001 | 1.41 (1.05–1.90) | 0.023 |
 Group IV | 1.20 (0.90–1.60) | 0.223 | 1.06 (0.77–1.48) | 0.709 |